FDA Drug Application (020711) for ZYBAN by GLAXOSMITHKLINE

Back to FDA Applications sponsored by GLAXOSMITHKLINE

Application Number020711
Product Number002
FormTABLET, EXTENDED RELEASE;ORAL
Dosage100MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameZYBAN
Active IngredientBUPROPION HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient BUPROPION HYDROCHLORIDE7


Back to FDA Applications sponsored by GLAXOSMITHKLINE